ask our doctors

Acute Coronary Syndromes

Get the facts on Acute Coronary Syndromes treatment, diagnosis, staging, causes, types, symptoms. Information and current news about clinical trials and trial-related data, Acute Coronary Syndromes prevention, screening, research, statistics and other Acute Coronary Syndromes related topics. We answer all your qestions about Acute Coronary Syndromes.

Question: Is invasive therapy for acute coronary syndromes preferable to non-invasive? Are there any political or economic reasons for doctors to favor one type of treatment over the other?

Answer: It depends on the patient. For some, invasive is better, and for others, non-invasive is. Every patient is different, and there are risks and benefits associated with each approach. Physicians try to do what is best for the patient, but insurance companies may not pay for what is best medically. They opt for what is best for their bottom line.


Acute Coronary Syndromes News

Study linking outcome in acute coronary syndromes to anti-PC published in ...

Reuters
This study measured anti-PC levels in samples from 1185 acute coronary syndrome (ACS) patients and shows for the first time that low anti-PC levels indicate poor prognosis in these patients, with a high risk for new cardiovascular events and even death ...
 

Racial Differences in the Association Between Carotid Plaque and Aortic and ...

Medscape
Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes. J Am Coll Cardiol 2007; 50: 319?326. Schuijf JD, Beck T, Burgstahler C, et al.. Differences in plaque composition and distribution in stable coronary ...
 

Merck Drug Cuts CV Risk, Increases Bleeds

MedPage Today
The TRACER trial, which is investigating the use of vorapaxar in acute coronary syndrome patients, also ran into trouble. Although the trial reached its required number of events for comparison of vorapaxar to placebo, the data safety monitoring board ...
 

SWITCH III: Bivalirudin is as safe as heparin after fondaparinux in PCI patients

TheHeart.Org
Washington, DC - The direct thrombin inhibitor bivalirudin (Angiomax, the Medicines Company) is as safe as standard-dose unfractionated heparin in acute coronary syndrome patients treated with upstream fondaparinux (Arixtra, GlaxoSmithKline) prior to ...
 

Research and Markets: Acute Coronary Syndrome (ACS) Therapeutics - Pipeline ...

SunHerald.com
GlobalData, the industry analysis specialist, has released its new report Acute Coronary Syndrome (ACS) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The report is an essential source of information and analysis on the global ACS ...
 

Low levels of lipid antibodies increase complications following heart attack

Medical Xpress
The present study in The International Journal of Cardiology shows that patients with low levels of anti-PC in connection with acute coronary syndromes and refractory, unstable angina run a greater risk of complications and premature death.
 

Appropriate use doc aims to guide revascularization decision making

Cardiovascular Business
The recommendations provide an update to 2009 data and outline the ins and outs of revascularization in acute coronary syndromes patients; however, the authors cautioned that these types of criteria should not substitute for clinical judgment.
 

CRT: How will generic clopidogrel affect US antiplatelet market?

Cardiovascular Business
WASHINGTON, DC?While the introduction of generic clopidogrel will undoubtedly impact the selection of antiplatelet drugs for patients with acute coronary syndromes (ACS), an expert panel at the Cardiovascular Research Technologies (CRT) meeting on Feb.
 

New appropriate use criteria reflect latest scientific data on restoring blood ...

Medical Xpress
The clinical scenarios, written by a group of cardiologists and cardiac surgeons, affirm the role of revascularization for patients with acute coronary syndromes and significant symptoms. "This document helps patients, physicians, and payers determine ...
 

New appropriate use criteria reflect latest scientific data on restoring blood ...

EurekAlert (press release)
The clinical scenarios, written by a group of cardiologists and cardiac surgeons, affirm the role of revascularization for patients with acute coronary syndromes and significant symptoms. "This document helps patients, physicians, and payers determine ...